v3.25.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning Balance at Dec. 31, 2023 $ 265,781 $ 5 $ 1,418,307 $ (1,152,531)
Beginning balance, shares at Dec. 31, 2023   52,508,602    
Exercise of stock options 38   38  
Exercise of stock options, shares   8,333    
Restricted stock units vested, shares   6,512    
Stock-based compensation expense 18,409   18,409  
Net Income (Loss) (43,039)     (43,039)
Ending Balance at Mar. 31, 2024 241,189 $ 5 1,436,754 (1,195,570)
Ending balance, shares at Mar. 31, 2024   52,523,447    
Beginning Balance at Dec. 31, 2023 265,781 $ 5 1,418,307 (1,152,531)
Beginning balance, shares at Dec. 31, 2023   52,508,602    
Net Income (Loss) (88,156)      
Ending Balance at Jun. 30, 2024 214,506 $ 5 1,455,188 (1,240,687)
Ending balance, shares at Jun. 30, 2024   52,614,729    
Beginning Balance at Mar. 31, 2024 241,189 $ 5 1,436,754 (1,195,570)
Beginning balance, shares at Mar. 31, 2024   52,523,447    
Restricted stock units vested, shares   64,476    
Proceeds from ESPP , Share   26,806    
Proceeds from ESPP 59   59  
Stock-based compensation expense 18,375   18,375  
Net Income (Loss) (45,117)     (45,117)
Ending Balance at Jun. 30, 2024 214,506 $ 5 1,455,188 (1,240,687)
Ending balance, shares at Jun. 30, 2024   52,614,729    
Beginning Balance at Dec. 31, 2024 150,288 $ 5 1,479,021 (1,328,738)
Beginning balance, shares at Dec. 31, 2024   52,726,916    
Exercise of stock options 124   124  
Exercise of stock options, shares   21,427    
Restricted stock units vested, shares   3,532    
Stock-based compensation expense 15,891   15,891  
Net Income (Loss) (57,461)     (57,461)
Ending Balance at Mar. 31, 2025 108,842 $ 5 1,495,036 (1,386,199)
Ending balance, shares at Mar. 31, 2025   52,751,875    
Beginning Balance at Dec. 31, 2024 150,288 $ 5 1,479,021 (1,328,738)
Beginning balance, shares at Dec. 31, 2024   52,726,916    
Net Income (Loss) (111,774)      
Ending Balance at Jun. 30, 2025 70,290 $ 5 1,510,797 (1,440,512)
Ending balance, shares at Jun. 30, 2025   52,821,689    
Beginning Balance at Mar. 31, 2025 108,842 $ 5 1,495,036 (1,386,199)
Beginning balance, shares at Mar. 31, 2025   52,751,875    
Exercise of stock options 38   38  
Exercise of stock options, shares   15,320    
Restricted stock units vested, shares   26,061    
Proceeds from ESPP , Share   28,433    
Proceeds from ESPP 82   82  
Stock-based compensation expense 15,641   15,641  
Net Income (Loss) (54,313)     (54,313)
Ending Balance at Jun. 30, 2025 $ 70,290 $ 5 $ 1,510,797 $ (1,440,512)
Ending balance, shares at Jun. 30, 2025   52,821,689